Lubrizol's Earnings Beat Analyst Estimates

Lubrizol’s first-quarter earnings rose 4% from the same period last year, to $169.5 million, including charges of $9.1 million related primarily to Berkshire Hathaway’s proposed acquisition of Lubrizol. Sales rose 15%, to $1.52 billion, on higher volumes and selling prices, and improved product mix. Adjusted earnings, excluding merger-related and restructuring costs of 14 cts/share, were $2.71/share, well above analysts’ consensus of $2.53/share as reported by Reuters Thomson (New York)....

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers